Literature DB >> 21302003

Update on HDL receptors and cellular cholesterol transport.

Ginny Kellner-Weibel1, Margarita de la Llera-Moya.   

Abstract

Efflux is central to maintenance of tissue and whole body cholesterol homeostasis. The discovery of cell surface receptors that bind high-density lipoprotein (HDL) with high specificity and affinity to promote cholesterol release has significantly advanced our understanding of cholesterol efflux. We now know that 1) cells have several mechanisms to promote cholesterol release, including a passive mechanism that depends on the physico-chemical properties of cholesterol molecules and their interactions with phospholipids; 2) a variety of HDL particles can interact with receptors to promote cholesterol transport from tissues to the liver for excretion; and 3) interactions between HDL and receptors show functional synergy. Therefore, efflux efficiency depends both on the arrays of receptors on tissue cells and HDL particles in serum.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21302003     DOI: 10.1007/s11883-011-0169-0

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  64 in total

1.  Scavenger receptor class B type I-mediated cholesteryl ester-selective uptake and efflux of unesterified cholesterol. Influence of high density lipoprotein size and structure.

Authors:  Stephen T Thuahnai; Sissel Lund-Katz; Padmaja Dhanasekaran; Margarita de la Llera-Moya; Margery A Connelly; David L Williams; George H Rothblat; Michael C Phillips
Journal:  J Biol Chem       Date:  2004-01-12       Impact factor: 5.157

2.  Influence of apolipoprotein (Apo) A-I structure on nascent high density lipoprotein (HDL) particle size distribution.

Authors:  Charulatha Vedhachalam; Palaniappan Sevugan Chetty; Margaret Nickel; Padmaja Dhanasekaran; Sissel Lund-Katz; George H Rothblat; Michael C Phillips
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

Review 3.  ATP-binding cassette transporter G1 and lipid homeostasis.

Authors:  Angel Baldán; Paul Tarr; Richard Lee; Peter A Edwards
Journal:  Curr Opin Lipidol       Date:  2006-06       Impact factor: 4.776

4.  MiR-33 contributes to the regulation of cholesterol homeostasis.

Authors:  Katey J Rayner; Yajaira Suárez; Alberto Dávalos; Saj Parathath; Michael L Fitzgerald; Norimasa Tamehiro; Edward A Fisher; Kathryn J Moore; Carlos Fernández-Hernando
Journal:  Science       Date:  2010-05-13       Impact factor: 47.728

5.  Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.

Authors:  Frank M Sacks; Lawrence L Rudel; Adam Conner; Hassibullah Akeefe; Gerhard Kostner; Talal Baki; George Rothblat; Margarita de la Llera-Moya; Bela Asztalos; Timothy Perlman; Chunyu Zheng; Petar Alaupovic; Jo-Ann B Maltais; H Bryan Brewer
Journal:  J Lipid Res       Date:  2009-01-14       Impact factor: 5.922

6.  Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1.

Authors:  Elda Favari; Laura Calabresi; Maria Pia Adorni; Wendy Jessup; Sara Simonelli; Guido Franceschini; Franco Bernini
Journal:  Biochemistry       Date:  2009-11-24       Impact factor: 3.162

7.  The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor.

Authors:  Chongren Tang; Yuhua Liu; Peter S Kessler; Ashley M Vaughan; John F Oram
Journal:  J Biol Chem       Date:  2009-09-25       Impact factor: 5.157

Review 8.  The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes.

Authors:  Chongren Tang; John F Oram
Journal:  Biochim Biophys Acta       Date:  2009-04-01

9.  Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo.

Authors:  Xun Wang; Heidi L Collins; Mollie Ranalletta; Ilia V Fuki; Jeffrey T Billheimer; George H Rothblat; Alan R Tall; Daniel J Rader
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 10.  Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses.

Authors:  Laurent Yvan-Charvet; Nan Wang; Alan R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-01       Impact factor: 8.311

View more
  9 in total

Review 1.  Crosstalk between reverse cholesterol transport and innate immunity.

Authors:  Kathleen M Azzam; Michael B Fessler
Journal:  Trends Endocrinol Metab       Date:  2012-03-10       Impact factor: 12.015

2.  Importance of evaluating cell cholesterol influx with efflux in determining the impact of human serum on cholesterol metabolism and atherosclerosis.

Authors:  Ginny L Weibel; Denise Drazul-Schrader; Debra K Shivers; Alisha N Wade; George H Rothblat; Muredach P Reilly; Margarita de la Llera-Moya
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-11-07       Impact factor: 8.311

Review 3.  Use of Primary Macrophages for Searching Novel Immunocorrectors.

Authors:  Nikita G Nikiforov; Natalia V Elizova; Michael Bukrinsky; Larisa Dubrovsky; Vsevolod J Makeev; Yoshiyuki Wakabayashi; Poching Liu; Kathy K Foxx; Howard S Kruth; Xueting Jin; Emile R Zakiev; Alexander N Orekhov
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 4.  Impact of Obesity and Metabolic Syndrome on Immunity.

Authors:  Catherine J Andersen; Kelsey E Murphy; Maria Luz Fernandez
Journal:  Adv Nutr       Date:  2016-01-15       Impact factor: 8.701

5.  Apolipoprotein mimetic peptides: a new approach for the treatment of asthma.

Authors:  Xianglan Yao; Michael P Vitek; Alan T Remaley; Stewart J Levine
Journal:  Front Pharmacol       Date:  2012-03-09       Impact factor: 5.810

6.  High Density Lipoprotein and it's Dysfunction.

Authors:  Esin Eren; Necat Yilmaz; Ozgur Aydin
Journal:  Open Biochem J       Date:  2012-07-27

7.  HDL, Atherosclerosis, and Emerging Therapies.

Authors:  Anouar Hafiane; Jacques Genest
Journal:  Cholesterol       Date:  2013-05-28

8.  Effects of Hormone Therapy on Oxidative Stress in Postmenopausal Women with Metabolic Syndrome.

Authors:  Martha A Sánchez-Rodríguez; Mariano Zacarías-Flores; Lizett Castrejón-Delgado; Ana Karen Ruiz-Rodríguez; Víctor Manuel Mendoza-Núñez
Journal:  Int J Mol Sci       Date:  2016-08-24       Impact factor: 5.923

9.  Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: effects of liver X receptor agonism.

Authors:  Ryohei Kaseda; Yohei Tsuchida; Hai-Chun Yang; Patricia G Yancey; Jianyong Zhong; Huan Tao; Aihua Bian; Agnes B Fogo; Mac Rae F Linton; Sergio Fazio; Talat Alp Ikizler; Valentina Kon
Journal:  BMC Nephrol       Date:  2018-01-27       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.